ghk-cu negatives Topical vs Injection GHK-CU - Research Peptide -

Kawai, S

There is no strong evidence suggesting gender-specific risks, but safety data is limited for both men and women

If VB12 is ingested in its protein-bound form, it must first undergo proteolytic cleavage in the stomach or duodenum where it will bind to an R-binder before entering the duodenum for further cleavage

For Research Purposes Only: This product is sold strictly for laboratory research use only and must be handled accordingly

The clinical symptoms that result from this process include progressive muscle weakness, atrophy, speech and swallowing difficulties, as well as respiratory complications (Mejzini et al., 2019